Omega Therapeutics
About:
Omega Therapeutics offers a proprietary epigenomic programming platform.
Website: https://www.omegatherapeutics.com/
Twitter/X: omegatx
Top Investors: BlackRock, Fidelity, Cowen Group, Invus, HarbourVest Partners
Description:
Omega Therapeutics, Inc. is a development-stage biotechnology company leveraging its proprietary epigenomic programming platform to biologically engineer a new class of programmable epigenetic medicines.
Total Funding Amount:
$279M
Estimated Revenue Range:
$10M to $50M
Headquarters Location:
Cambridge, Massachusetts, United States
Founded Date:
2016-01-01
Contact Email:
ArgotOmega(AT)argotpartners.com
Founders:
David Berry, Noubar Afeyan, Richard Young
Number of Employees:
101-250
Last Funding Date:
2023-02-23
IPO Status:
Public
Industries:
© 2025 bioDAO.ai